Heart failure highlights in 2012-2013.
Heart failure has become the cardiovascular epidemic of the century. The European Journal of Heart Failure is dedicated to the advancement of knowledge in the field of heart failure management. In 2012 and 2013, several pioneering scientific discoveries and paradigm-shifting clinical trials have been published. In the current paper, we will discuss the most significant novel insights into the pathophysiology, diagnosis, and treatment of heart failure that were published during this period. All relevant research areas are discussed, including pathophysiology, co-morbidities, arrhythmias, biomarkers, clinical trials, and device therapy, including left ventricular assist devices.
The Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Licette C Y
LC
Liu
Kevin
K
Damman
Eric
E
Lipsic
Alexander H
AH
Maass
Michiel
M
Rienstra
B Daan
BD
Westenbrink
D001145:Arrhythmias, Cardiac / Q000150:complications / Q000628:therapy*; D015415:Biomarkers; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006353:Heart-Assist Devices; D006801:Humans
D015415:Biomarkers; D002317:Cardiovascular Agents
Assist devices; Atrial fibrillation; Biomarkers; CRT; Co-morbidities; Heart failure; Highlights 2012/13; Interventional treatment; Pathophysiology; Pharmacological therapy